Xilio Therapeutics Cash from Financing (TTM) Trends

Xilio Therapeutics Inc (XLO)

1.08 -0.10 (-8.47%) USD | NASDAQ | May 13, 09:46

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2021. Upgrade now.

Date	Value
December 31, 2023	-6.55M
September 30, 2023	-4.937M
June 30, 2023	-2.723M
March 31, 2023	-1.752M
December 31, 2022	-0.069M

Date	Value
September 30, 2022	115.78M
June 30, 2022	116.10M
March 31, 2022	115.77M
December 31, 2021	260.67M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-6.55M

Minimum

Dec 2023

260.67M

Maximum

Dec 2021

65.81M

Average

-0.069M

Median

Dec 2022

Cash from Financing (TTM) Benchmarks